Hercules Capital brings a conservative yet flexible BDC strategy and a focus on innovative companies. Read why dividend ...

In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...

Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

Analyst firms such as H.C. Wainwright and Piper Sandler have maintained their Buy and Overweight ratings respectively, showing confidence in Tenaya's ongoing developments. However, the company has ...

Tenaya is conducting the RIDGE-1 Phase 1b clinical trial of TN-401 in patients with PKP2-associated ARVC. To support TN-401’s clinical development, the company is currently enrolling the RIDGE ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Dr. Harold Naiman, pediatrician at Intermountain Health Tenaya Pediatrics Clinic said prevention with the flu vaccine is especially helpful. “If you can get ahead of the problem, I think the best ...

Amid these developments, Tenaya announced the departure of Leone Patterson, its Chief Financial and Business Officer, and is currently seeking a replacement. Despite this, analyst firms such as H ...